DMII:NASDAQ, Drugs Made In America Acquisition II Corp.

DMII stock overview

Drugs Made In America Acquisition II Corp. (DMII:NASDAQ) closed at $10.25 on November 17, 2026, up 0.02% on the day. The stock trades 0.8% below its 52-week high of $10.33 and 3.9% above its 52-week low of $9.86. Over the past year, it gained 3.7%. Drugs Made In America Acquisition II Corp. is part of the Funds & Shells sector.

Key figures

Price
$10.25
Day change
+0.02%
Volume
6,734
Average volume
120,740
Market cap
652M+
52-week range
$9.86 – $10.33
50-day average
$10.19
200-day average
$10.08

Price action over the past year

In 240 trading sessions since December 4, 2025, DMII closed higher on 84 days (35%). Its best day was December 19, 2025 (+0.51%) and its worst was December 22, 2025 (-0.40%). It never moved 10% or more in a single session.

Recent signals

Similar stocks

Find more stocks like DMII with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.